Considerations for the New Four-Month Rifapentine-Moxifloxacin Regimen for Drug-Susceptible TB
Please join us on September 21 at 2 PM Eastern for the national webinar “Considerations for the New Four-Month Rifapentine-Moxifloxacin Regimen for Drug-Susceptible TB in the U.S.”.
Registration is closed. This event has already been held.
Considerations for the New Four-Month Rifapentine-Moxifloxacin Regimen for Drug-Susceptible TB